A rich formula for Nestlé

The Lex team's Nikki Tait and Richard Stovin-Bradford examine why Nestlé has paid generously for Pfizer’s nutrition business, which sells speciality infant formulas. They point to the importance of Asian markets for the Swiss food conglomerate.